Tradestie Institutional Equity Comparison Engine

SKIN vs FIGS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

FIGS Overall Edge

FIGS Captures Institutional Edge (3โ€“1 Pillars ยท 9โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to FIGS, Inc. (FIGS) driven by superior Valuation, Growth & Margin, Options & Structure while SKIN counters with relative strength in Momentum & Technical. Fundamentally, SKIN trades at 106.4x Forward P/E with 2.4% operating margin (-2.1% YoY revenue) versus FIGS at 49.2x Forward P/E and 9.7% operating margin (+25.7% YoY). In options structure, SKIN sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against FIGS sits in BREAKOUT (38th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner FIGS
SKIN 106.4x vs FIGS 49.2x Fwd P/E
Growth & Margin Winner FIGS
Op Margin 2.4% vs 9.7% ยท YoY -2.1% vs +25.7%
Momentum & Technical Winner SKIN
1Y +1057.7% vs +127.0% ยท 52W Pos 83% vs 84%
Options & Structure Winner FIGS
UNCLASSIFIED (100th %ile IV) vs BREAKOUT (38th %ile IV)
SKIN NASDAQ
The Beauty Health Company Class A Common Stock
Surgical & Medical Instruments & Apparatus
$15.05
-7.73% 1D
Market Cap $106.3M
1M Return +42.52%
1Y Return +1057.69%
Forward P/E 106.4x
Unified AI Score
34.1 / 100 SELL
Tech 50.0 Fund 34.0 Flow 67.0 Mom 46.0
FIGS NYSE
FIGS, Inc.
Apparel & Other Finishd Prods Of Fabrics & Similar Matl
$21.34
-3.22% 1D
Market Cap $3.7B
1M Return +11.61%
1Y Return +127.02%
Forward P/E 49.2x
Unified AI Score
43.7 / 100 HOLD
Tech 30.0 Fund 35.0 Flow 68.0 Mom 1.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SKIN +1057.69% FIGS +127.02% Spread: +930.67 pp (SKIN Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period SKIN Revenue FIGS Revenue SKIN Op. Margin FIGS Op. Margin Margin Edge
FY2019 $170M $110M 8.1% -0.3% SKIN
FY2020 $120M $260M -14.4% 22.0% FIGS
FY2021 $260M $420M -15.4% 2.6% FIGS
FY2022 $370M $510M -7.1% 7.4% FIGS
FY2023 $400M $550M -32.9% 6.2% FIGS
FY2024 $330M $560M -20.3% 0.4% FIGS
FY2025 $300M $630M -6.9% 6.0% FIGS

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SKIN (0) vs FIGS (9)
Institutional Metric SKIN FIGS Criterion Row Winner
Market Capitalization Scale $106.3M $3.7B Larger Scale FIGS
Trailing P/E Ratio Valuation 106.4x 58.0x Lower Multiple FIGS
Forward P/E Ratio Valuation 106.4x 49.2x Lower Multiple FIGS
Revenue Growth (YoY) Growth -2.1% +25.7% Higher Growth FIGS
Operating Margin (TTM) Profitability 2.4% 9.7% Higher Margin FIGS
Net Profit Margin Profitability -6.3% 9.7% Higher Margin FIGS
Return on Equity (ROE) Capital Efficiency -30.1% 16.8% Higher ROE FIGS
52-Week Range Position Momentum 83% ($0โ€“$18) 84% ($9โ€“$24) Stronger Trend Tie
Beta / 30D Volatility Risk Regime -14.22ฮฒ ยท 192% Vol 1.10ฮฒ ยท 59% Vol Lower Realized Risk FIGS
Unified Institutional Score Composite Signal 34.1 / 100 (SELL) 43.7 / 100 (HOLD) Higher Composite FIGS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SKIN vs FIGS Buy Guide
SKIN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live SKIN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
FIGS BREAKOUT
22d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 38th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live FIGS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SKIN nor FIGS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.